Skip Navigation Links

Bookmark and Share
Prokarium Closes $21M Series B Financing Round and Strengthens Board
- Industry veteran, Hyam Levitsky, MD, appointed to Prokarium’s Board of Directors - Financing will support the clinical development of Prokarium’s microbial immunotherapy for non-muscle invasive bladder cancer as well as expansion of pipeline across...

Full "IntellAsia: Resources" article

Disclaimer | Terms Of Use And Privacy Statement

© Metals News. All rights reserved.